Who makes HTS-519 Insert?

HTS-519 Insert is developed by Hallux, Inc..

Last reviewed 2026-04-19 · How we verify

HTS-519 Insert

Hallux, Inc. · Phase 2 active Small molecule

At a glance

Generic name	HTS-519 Insert
Also known as	HTS-519 Biodegradable Micro Insert
Sponsor	Hallux, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HTS-519 Insert CI brief — competitive landscape report
HTS-519 Insert updates RSS · CI watch RSS
Hallux, Inc. portfolio CI